We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bill Aims To Create Approval Process For Biosimilars

Law360 (March 11, 2009, 12:00 AM EDT) -- A bipartisan group of lawmakers has introduced a bill that would create a regulatory process allowing the U.S. Food and Drug Administration to approve affordable generic versions of biologic drugs.

H.R. 1427, the “Promoting Innovation and Access to Life-Saving Medicine Act,” aims to give the FDA the power to authorize an approved copy of a biologic drug, and assure consumers that it is just as safe as the original product. It was introduced by Rep. Henry Waxman, D-Calif., chairman of the House Committee on Energy and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.